The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of differential expression of genes with survival and relapse in patients treated on the BILCAP clinical trial: Gene expression identification and response to adjuvant chemotherapy in early-stage biliary tract cancer.
 
Valerie Crolley
Honoraria - AstraZeneca
 
Rachel Guest
No Relationships to Disclose
 
Andrew Beggs
Honoraria - Illumina
Consulting or Advisory Role - 2CureX; Birmingham Biotech; Check4Cancer; Oxford Nanopore Technologies
Research Funding - AstraZeneca; Incyte; Oxford Nanopore Technologies
Patents, Royalties, Other Intellectual Property - IP on HLA Long Read sequencing; IP on RTF-ExPAR
Travel, Accommodations, Expenses - Oxford Nanopore Technologies
 
Eleanor Jaynes
No Relationships to Disclose
 
Steve Thorn
No Relationships to Disclose
 
Ian Tomlinson
No Relationships to Disclose
 
Juan Valle
Consulting or Advisory Role - AstraZeneca; Cogent Biosciences (Inst); Incyte; Jazz Pharmaceuticals; Jazz Pharmaceuticals (Inst); Oncosil (Inst); Owkin (Inst); Redx Pharma (Inst); SERVIER; Taiho Oncology
 
John Primrose
Honoraria - AstraZeneca
Speakers' Bureau - Angiodynamics
Travel, Accommodations, Expenses - Takeda
 
John Bridgewater
Honoraria - Incyte; SERVIER
Consulting or Advisory Role - AstraZeneca; Basilea; Bayer; Incyte; Merck Serono; Roche; SERVIER; Taiho Oncology
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene
Research Funding - Amgen; Incyte (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb/Medarex; Merck Serono; MSD Oncology; SERVIER